ATRA stock · STE stock

ATRA vs STE

Atara Biotherapeutics Inc (ATRA) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.

Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.

STERIS plc (STE) is a medical devices company listed on NYSE.

Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.

Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.

ATRA currently screens at market cap $87.1M. STE currently screens at market cap $19.43B and trailing P/E 25.1.

Not investment advice. Open the ATRA and STE stock pages for the full models.

Not investment advice.

Popular Stock Comparisons